Radiographic Evaluation of Tumor Biology During Neoadjuvant Radiotherapy for Sarcoma

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

1. Patients must have histologically or cytologically confirmed history of soft tissue sarcoma.
2. Plan to receive neoadjuvant radiation to a dose of 50 Gy in 25 fractions followed by surgical resection per Investigator.
3. Age ≥18 years.
4. ECOG performance status ≤2.

Exclusion Criteria:

1. Patients with Ewing's sarcoma and rhabdomyosarcoma.
2. Unable or unwilling to receive gadolinium-based contrast.
3. Patients who are unable or unwilling to undergo MRI studies.
4. Patients who may be unlikely or unable to be able to complete 3 additional MRI studies during the course of their 5-week radiation plan in the opinion of the PI.